Roquefort Therapeutics Plc (ROQAF) Discusses Acquisition Of Coiled Therapeutics Call (Transcript)
Source: SeekingAlpha
2025-09-29 16:18:56 ET
Roquefort Therapeutics plc (ROQAF) Acquisition Of Coiled Therapeutics Call
Company Participants
Stephen West - Executive Chairman
Edward Painter - Co-Founder, Chairman & CIO
Sridhar Vempati - Co-Founder, Director, Chief Strategy Officer & EVP of R&D ...
Read the full article on Seeking Alpha
For further details see:
Roquefort Therapeutics Plc (ROQAF) Discusses Acquisition Of Coiled Therapeutics Call (Transcript)
Roquefort Therapeutics
NASDAQ: ROQAF
ROQAF Trading
0.0% G/L:
$0.02135 Last:
1,000 Volume:
$0.02135 Open:
ROQAF Latest News
ROQAF Stock Data
$2,369,555
87,184,977
20.2%
N/A
Biotechnology & Life Sciences
Healthcare
GB
London
